In the past few years, the development of ultrasensitive digital immunoassay technologies has enabled the accurate measurement in blood of newly emerging biomarkers of neuroaxonal injury—neurofilament light protein (NF‐L) and tau—that have received considerable interest and shown great potential in sports‐related concussion and mild TBI. Here, MAPT is linked to brain injury.